Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Knilonat 150mg Capsule: Pioneering Treatment for Chronic Myeloid Leukemia
Introduction:
Knilonat 150mg Capsule stands as a beacon of hope in the realm of cancer therapeutics, specifically designed for the treatment of chronic myeloid leukemia. Tailored for patients who have not responded to alternative leukemia medications or are unable to tolerate them due to side effects, Knilonat 150mg Capsule offers a ray of optimism.
Usage of Knilonat 150mg Capsule:
Prescribed to be taken on an empty stomach, Knilonat 150mg Capsule is most effective when administered at a consistent time daily. The appropriate dosage and frequency are determined by the treating physician based on the specific condition being addressed. Strict adherence to the prescribed regimen is crucial, as incorrect administration or overdose can lead to severe side effects. While the therapeutic benefits may take weeks or months to manifest, discontinuation of the medication should only occur under the guidance of the healthcare professional.
Uses of Knilonat 150mg Capsule:
Knilonat 150mg Capsule finds its primary use in the treatment of chronic myeloid leukemia, a form of blood cancer. Its mechanism of action involves eliminating or inhibiting the growth of cancer cells, preventing their uncontrolled multiplication. Recognized as a potent and highly toxic medication, a thorough discussion of associated risks and benefits with the healthcare provider is essential. Patients are advised to abstain from alcohol consumption and maintain adequate hydration during the course of treatment.
Mechanism of Action of Knilonat 150mg Capsule:
Functioning as an anti-cancer medication, Knilonat 150mg Capsule works by hindering the abnormal protein responsible for signaling cancer cells to proliferate. This interference proves instrumental in halting or slowing down the spread of cancer cells, contributing to the overall therapeutic effect.